One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source uses indexed renal thresholds but prints an unindexed Cockcroft-Gault formula; preserve the distinction rather than silently treating the units as equivalent.
The label mirror uses a daily renal regimen with a timing-dependent post-HD supplement. UCSF also offers a selected post-HD-only strategy, with toxicity, age and low-weight qualifications. The source renal units and exactly-30 boundary do not align automatically.
What to reconcile: Use one complete protocol with the dialysis prescription and ID/pharmacy review. Do not add the label supplement to an institutional post-HD dose or silently equate indexed and unindexed clearance.
Open this note and its source referencesThe label mirror says a supplement is needed within six hours but not needed when the dose is at least six hours before dialysis. The boundary is overlapping as printed.
What to reconcile: Clarify the timing endpoint with the controlling product label and dialysis pharmacist. Do not round an administration time to decide which instruction applies.
Open this note and its source referencesUCSF lists 1 g IV every 24 hours above CrCl 30 and 500 mg every 24 hours below 30; exactly 30 is not assigned by its printed inequalities. Intermittent HD: 500 mg once now, then each evening; alternatively 500 mg to 1 g once now, then after HD. The post-HD-only strategy is case-by-case because of toxicity risk; consider 500 mg in advanced age or body weight under 40 kg and consult ID pharmacy. Continuous HD: 1 g every 24 hours. Do not generalize that row to all CRRT prescriptions.
RDM43-professional-ertapenem-b0bd191d14-C1 · Source locator: Adult non-dialysis and intermittent/continuous hemodialysis tables; post-HD footnote.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ertapenem&s1=RDM43-professional-ertapenem-b0bd191d14&h1=993f7fd23bfde5bbbafbf7a8c2866729cf8451d4a1ff5b4a4184d2e2bfb25894